Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Short term Debt (2017 - 2022)

Historic Short term Debt for Nephros (NEPH) over the last 8 years, with Q4 2022 value amounting to $71000.0.

  • Nephros' Short term Debt fell 7137.1% to $71000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $71000.0, marking a year-over-year decrease of 7137.1%. This contributed to the annual value of $71000.0 for FY2022, which is 7137.1% down from last year.
  • Per Nephros' latest filing, its Short term Debt stood at $71000.0 for Q4 2022, which was down 7137.1% from $141000.0 recorded in Q3 2022.
  • Nephros' Short term Debt's 5-year high stood at $1.0 million during Q2 2019, with a 5-year trough of $71000.0 in Q4 2022.
  • Moreover, its 5-year median value for Short term Debt was $235500.0 (2021), whereas its average is $391350.0.
  • Its Short term Debt has fluctuated over the past 5 years, first soared by 44598.93% in 2019, then plummeted by 7845.25% in 2020.
  • Over the past 5 years, Nephros' Short term Debt (Quarter) stood at $991000.0 in 2018, then plummeted by 43.49% to $560000.0 in 2019, then plummeted by 59.11% to $229000.0 in 2020, then rose by 8.3% to $248000.0 in 2021, then plummeted by 71.37% to $71000.0 in 2022.
  • Its Short term Debt stands at $71000.0 for Q4 2022, versus $141000.0 for Q3 2022 and $210000.0 for Q2 2022.